IMI Pain Care

IMI-PainCare is an international public-private partnership project*, aiming at improving the care of patients suffering from acute or chronic pain. The project addresses three different topics: Patient reported outcome measures to improve management of acute and chronic pain (subproject PROMPT), Pharmacological validation of functional pain biomarkers in healthy subjects and animals (BioPain), and Improving translation in chronic pelvic pain (TRiPP).

After three years (total adjusted project duration is 5 years), the PainCare project (www.imi-paincare.eu) can show considerable progress.

In subproject PROMPT, more than 2,000 patients could be included in the prospective data collection. This data collection is expected to show which tools work best for assessing pain management after surgery. 19 hospitals across Europe collect data at 6 timepoints, providing first-hand information about how patients feel after surgery. In addition, a feasibility study about use of an activity tracker to correlate physical movement with pain has shown very promising results. Moreover, several systematic literature researches on post-op pain, pain chronification, chronic neuropathic and pelvic pain have been finished, first manuscripts are published. Thus, the overall goal to provide standardized consented patient-reported outcome measures to improve pain treatment gets closer.

EFIC is a consortium member of the PROMPT subproject and actively support the project by giving scientific advice, fostering PR and dissemination.

Progress reports about subprojects BioPain and TRiPP will be published in the next newsletters.

*IMI-PainCare has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 777500. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. www.imi.europa.eu

The statements and opinions presented here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.

EFPIA